Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Long term follow-up of the STOPAGO study

Blood blood.2024025707.

https://doi.org/10.1182/blood.2024025707

Published: 2024

Includes: Supplemental data

Journal Articles

Long-Term Follow-up of Hypereosinophilic Syndrome Patients Treated with Mepolizumab: A Nationwide Real-Life Study of 59 Patients

Kevin Chevalier, Francois Barde, Alexandre Vallée, Lucile Grange, Gerard Socié, Stanislas Faguer, Antoine Néel, Camille Taillé, Pascal Cathebras, Daniele Belgodere, Divi Cornec, Bernard Bonnotte, Guillaume Lefèvre, Matthieu Groh, Jean-Emmanuel Kahn

Blood (2023) 142 (Supplement 1): 5060.

https://doi.org/10.1182/blood-2023-182004

Published: 2023

Journal Articles

Efficacy and Safety of Dapsone in Primary Immune Thrombocytopenia. Results of a Randomized, Placebo-Controlled Multicenter Trial and of a Single-Arm, Emulated Trial in the Prospective, Multicenter Carmen-France Registry

Marion Larue, Guillaume Moulis, Manuela Rueter, Sylvain Audia, Louis Terriou, Jean-Francois Viallard, Brigitte Pan Petesch, Bruno Royer, Bernard Bonnotte, Lionel Galicier, Olivier Lambotte, Francois Lefrere, Stephane Cheze, Mikael Ebbo, Orianne Wagner-Ballon, Matthieu Mahevas, Bertrand Godeau, Marc Michel

Blood (2023) 142 (Supplement 1): 3983.

https://doi.org/10.1182/blood-2023-181606

Published: 2023

Journal Articles

Evaluation of the Efficacy and Safety during Treatment with TPO-Ras in 40 SLE-ITP and APS-ITP Patients

Marques Cindy, Mickael Roussotte, Guillaume Moulis, Bernard Bonnotte, Jean-Francois Viallard, Nathalie Costedoat-Chalumeau, Alban Deroux, Pascal Sève, Bertrand Godeau, Matthieu Mahevas, Marc Michel

Blood (2023) 142 (Supplement 1): 1209.

https://doi.org/10.1182/blood-2023-187461

Published: 2023

Journal Articles

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents

Natasha Ollier, Marie-Léa Piel-Julian, Matthieu Mahévas, Jean-François Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikaël Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau, Guillaume Moulis

Blood (2023) 142 (12): 1099–1101.

https://doi.org/10.1182/blood.2023020311

Published: 2023

Includes: Supplemental data

Journal Articles

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Blood (2023) 141 (23): 2867–2877.

https://doi.org/10.1182/blood.2022018665

Published: 2023

Includes: Supplemental data

Journal Articles

Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry

Natacha Ollier, Marie-Léa Piel-Julian, Matthieu Mahevas, Jean-Francois Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikael Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau, Guillaume Moulis

Blood (2022) 140 (Supplement 1): 52–54.

https://doi.org/10.1182/blood-2022-157715

Published: 2022

Journal Articles

Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry

Guillaume Moulis, Manuela Rueter, Matthieu Mahevas, Jean-Francois Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikael Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau

Blood (2022) 140 (Supplement 1): 5557–5558.

https://doi.org/10.1182/blood-2022-157723

Published: 2022

Journal Articles

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

Blood (2021) 138 (Supplement 1): 583.

https://doi.org/10.1182/blood-2021-152767

Published: 2021

Journal Articles

Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment

Blood (2021) 138 (Supplement 1): 17.

https://doi.org/10.1182/blood-2021-147450

Published: 2021

Journal Articles

Efficacy and Tolerance of Interferon-α in Hypereosinophilic Syndromes. a Retrospective Multicenter Study on 29 Patients

Pauline De Malglaive, MD, Matthieu Groh, MD, Guillaume Lefèvre, MD PhD, Chafika Morati Hafsaoui, MD, Magda Alexis, MD, Mathilde Hunault, MD PhD, Julien Seneschal, MD PhD, Hilaire Charlanne, MD, Claude Preudhomme, PharmD, PhD, Bernard Bonnotte, MD PhD, Jean Emmanuel Kahn, PhDMD

Blood (2019) 134 (Supplement_1): 2322.

https://doi.org/10.1182/blood-2019-131687

Published: 2019

Journal Articles

High Incidence of Venous Thromboembolism Events during Warm Autoimmune Hemolytic Anemia

Sylvain Audia, MD PhD, Benoit Bach, MD, Maxime Samson, MD PhD, Vanessa Leguy, MD, Sabine Berthier, MD, Bernard Bonnotte, MD PhD

Blood (2016) 128 (22): 2448.

https://doi.org/10.1182/blood.V128.22.2448.2448

Published: 2016

Journal Articles

How to Treat Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patients : Results on 86 Patients of the French BPDCN Network

Eve Poret, Chrystelle Vidal, Yohan Desbrosses, Fanny Angelot Delettre, Maider Pagadoy, Aurore Pugin, Louis Benazet, Franck Leroux, Elise Robert, Delphine Binda, Sabeha Biichle, Anne Roggy, PhDSTUDENT, Laure Philippe, MDcal student, Berengere Gruson, Anne-Claire Gac, Michel Maigre, Denis Caillot, Remy Gressin, MD, Pascal Turlure, MD, Anne-Sophie Michallet, MD, Lila Gilis, Veronique Dorvaux, Yazid Arkam, Caroline Bonmati, MD, Pierre Péterlin, Pierre-Simon Rohrlich, MD PhD, Thorsten Braun, MD PhD, jean-Valere Malfuson, Didier Bouscary, MDPhD, Eric Pujade-Lauraine, Felipe Suarez, MD PhD, Carole Soussain, MD, Etienne Lengliné, MD, Mathieu Puyade, MD, Tony Marchand, MD, Denis Guyotat, Bruno Lioure, MD, Christian Recher, MD, Damien Roos-Weil, Fabrice Jardin, Jean-Pierre Marolleau, Bernard Drenou, MD, Bernard Bonnotte, MD PhD, Sophie Dalac, Philippe Saas, PhD, Francine Garnache Ottou, PhD, Eric Deconinck

Blood (2015) 126 (23): 456.

https://doi.org/10.1182/blood.V126.23.456.456

Published: 2015

Journal Articles

Splenic and Circulating Human T Follicular Helper Cell Regulation By B Cell Depleting Therapy during Immune Thrombocytopenia

Sylvain Audia, MD PhD, Marzia Rossato, PhD, Maxime Samson, MD PhD, Malika Trad, PhD, Kim Santegoets, PhD, Alexandrine Gautheron, PhD, Olivier Facy, MD PhD, Pablo Ortega-Deballon, MD PhD, Laurent Martin, MD PhD, Marion Ciudad, Nona Janikashvili, PhD, Philippe Saas, PhD, Timothy Radstake, MD PhD, Bernard Bonnotte, MD PhD

Blood (2015) 126 (23): 8.

https://doi.org/10.1182/blood.V126.23.8.8

Published: 2015

Journal Articles

Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia

Blood (2014) 124 (18): 2858–2866.

https://doi.org/10.1182/blood-2014-03-563445

Published: 2014

Journal Articles

Preferential splenic CD8 + T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia

Blood (2013) 122 (14): 2477–2486.

https://doi.org/10.1182/blood-2013-03-491415

Published: 2013

Includes: Supplemental data

Journal Articles

A case-control study to assess the risk of immune thrombocytopenia associated with vaccines

Blood (2012) 120 (25): 4938–4944.

https://doi.org/10.1182/blood-2012-05-431098

Published: 2012

Includes: Supplemental data

Journal Articles

Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in France – Interim Results From a Large Observational Study

Philippe Quittet, MD, Mohamed Hamidou, Bernard Bonnotte, M.D., Ph.D., Olivier Fain, Kerry Dillingham, Georg Kreuzbauer, MD

Blood (2012) 120 (21): 4643.

https://doi.org/10.1182/blood.V120.21.4643.4643

Published: 2012

Journal Articles

Cost Effectiviness of Rituximab Given At Fixed Dose (1000 mg on days 1 and 15) Compared to the Standard Regimen in adult's Immune Thrombocytopenia.

Matthieu Mahévas, Mikael Ebbo, Sylvain Audia, M.D., Ph.D., Bernard Bonnotte, M.D., Ph.D., Nicolas Schleinitz, MD, PhD, Corinne Haioun, MD, PhD, Medhi Khellaf, Bertrand Godeau, MD, Marc Michel IV

Blood (2012) 120 (21): 2157.

https://doi.org/10.1182/blood.V120.21.2157.2157

Published: 2012

Journal Articles

Failure of Rituximab in Immune Thrombocytopenia Is Associated with the Activation of Splenic CD8 T Cells

Sylvain Audia, M.D., Ph.D., Maxime Samson, M.D., Malika Trad, Ph.D., Nona Janikashvili, Ph.D., Denis Caillot, M.D., Laurent Martin, M.D., Ph.D., Bernard Lorcerie, M.D., Philippe Saas, Ph.D., Bernard Bonnotte, M.D., Ph.D.

Blood (2012) 120 (21): 623.

https://doi.org/10.1182/blood.V120.21.623.623

Published: 2012

NARROW

Long term follow-up of the STOPAGO study

Long-Term Follow-up of Hypereosinophilic Syndrome Patients Treated with Mepolizumab: A Nationwide Real-Life Study of 59 Patients

Efficacy and Safety of Dapsone in Primary Immune Thrombocytopenia. Results of a Randomized, Placebo-Controlled Multicenter Trial and of a Single-Arm, Emulated Trial in the Prospective, Multicenter Carmen-France Registry

Evaluation of the Efficacy and Safety during Treatment with TPO-Ras in 40 SLE-ITP and APS-ITP Patients

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry

Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment

Efficacy and Tolerance of Interferon-α in Hypereosinophilic Syndromes. a Retrospective Multicenter Study on 29 Patients

High Incidence of Venous Thromboembolism Events during Warm Autoimmune Hemolytic Anemia

How to Treat Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patients : Results on 86 Patients of the French BPDCN Network

Splenic and Circulating Human T Follicular Helper Cell Regulation By B Cell Depleting Therapy during Immune Thrombocytopenia

Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia

Preferential splenic CD8 + T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia

A case-control study to assess the risk of immune thrombocytopenia associated with vaccines

Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in France – Interim Results From a Large Observational Study

Cost Effectiviness of Rituximab Given At Fixed Dose (1000 mg on days 1 and 15) Compared to the Standard Regimen in adult's Immune Thrombocytopenia.

Failure of Rituximab in Immune Thrombocytopenia Is Associated with the Activation of Splenic CD8 T Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only